Drug

HRS-5965 clinical trials

Also written HRS-5965.

studies test it: 13
open now: 2
in phase 3: 3
first study started: 2022

Keep track of what changes. Save the HRS-5965 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

HRS-5965 Capsules: 5
HRS-5965 capsule: 3
HRS-5965 tablets: 2

Development codes

HRS-5965: 3

Studies by the year they started

13 studies that test it; most in 2024 (5)

Studies that test HRS-5965, by start year
Year	Studies
2022	1
2023	2
2024	5
2025	4
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 6
Phase 2: 4
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it.

Glomerulonephritis, IGA: 4
Hemoglobinuria, Paroxysmal: 3
Anemia, Hemolytic: 2
Glomerulonephritis: 1
Hemoglobinuria: 1

Who runs them

Industry 13 · Other 0

Chengdu Suncadia Medicine Co., Ltd. (13)

Often tested with

Tested in the same studies.

Eculizumab (1) · Clopidogrel (1) · Clarithromycin (1)

Studies

Open first, then newest update. How each study uses HRS-5965 is read from its arms, and is right about nine times in ten.